Fellow of The Academy of Medical Sciences, United Kingdom
His primary scientific interests are in Cell biology, Biochemistry, Phosphorylation, Tau protein and Molecular biology. His Cell biology research incorporates elements of Epitope, Neurite and Nervous system. The Phosphorylation study combines topics in areas such as Tyrosine, Microtubule and Transfection.
As part of his inquiry into Pathology and Alzheimer's disease, Brian H. Anderton is doing Tau protein research. His studies in Pathology integrate themes in fields like Cytoplasm, Ubiquitin and Neuroscience. Brian H. Anderton focuses mostly in the field of Molecular biology, narrowing it down to topics relating to Tyrosine phosphorylation and, in certain cases, Receptor tyrosine kinase, PTK2 and Protein tyrosine phosphatase.
His main research concerns Cell biology, Pathology, Biochemistry, Neurofilament and Phosphorylation. His work carried out in the field of Cell biology brings together such families of science as Neurodegeneration and Cytoskeleton. His work is connected to GSK-3, Protein kinase A and Glycogen synthase, as a part of Biochemistry.
His Neurofilament research integrates issues from Protein filament, Immunostaining, Molecular biology and Antibody, Monoclonal antibody. His Phosphorylation research incorporates themes from Tyrosine, Tau protein and Kinase. The study incorporates disciplines such as Progressive supranuclear palsy, Tyrosine kinase, Neuroscience, Tauopathy and Gene isoform in addition to Tau protein.
Brian H. Anderton mainly focuses on Cell biology, Tau protein, Biochemistry, Phosphorylation and GSK-3. The various areas that Brian H. Anderton examines in his Cell biology study include Cleavage and Transcription, Gene. Within the field of Pathology and Alzheimer's disease Brian H. Anderton studies Tau protein.
Brian H. Anderton interconnects Neurofilament and Mass spectrometry in the investigation of issues within Biochemistry. His Phosphorylation study often links to related topics such as Tyrosine. His GSK-3 research includes elements of Glycogen synthase and MAP2K7.
His primary areas of investigation include Phosphorylation, Tau protein, Cell biology, Axoplasmic transport and Biochemistry. His biological study spans a wide range of topics, including Molecular biology and Tyrosine. His Tau protein research is multidisciplinary, incorporating elements of Genetically modified mouse, Neuroscience and Tauopathy.
His Neuroscience study combines topics from a wide range of disciplines, such as Tau phosphorylation, Tau pathology and Disease, Pathology. The concepts of his Cell biology study are interwoven with issues in Alzheimer's disease, Neurofilament and Neurodegeneration. His study in Hippocampal formation is interdisciplinary in nature, drawing from both Glycogen synthase and GSK-3.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.
Diane P. Hanger;Brian H. Anderton;Wendy Noble.
Trends in Molecular Medicine (2009)
Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.
Diane P. Hanger;Kenneth Hughes;James R. Woodgett;Jean-Pierre Brion.
Neuroscience Letters (1992)
All classes of intermediate filaments share a common antigenic determinant defined by a monoclonal antibody
Rebecca M. Pruss;Rhona Mirsky;Martin C. Raff;Robin Thorpe.
Cell (1981)
Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants
BH Anderton;D Breinburg;MJ Downes;PJ Green.
Nature (1982)
Phosphorylation sites on Tau identified by nanoelectrospray mass spectrometry : Differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and p38, and glycogen synthase kinase-3β
C H Reynolds;J C Betts;W P Blackstock;A R Nebreda.
Journal of Neurochemistry (2002)
New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry.
Diane P. Hanger;Joanna C. Betts;Thérèse L. F. Loviny;Walter P. Blackstock.
Journal of Neurochemistry (2002)
Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis
Diane P. Hanger;Helen L. Byers;Selina Wray;Kit-Yi Leung.
Journal of Biological Chemistry (2007)
Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity.
P. N. Leigh;H. Whitwell;O. Garofalo;J. Buller.
Brain (1991)
Glycogen synthase kinase-3 inhibition is integral to long-term potentiation.
Claudie Hooper;V Markevich;Florian Plattner;Richard Killick.
European Journal of Neuroscience (2007)
Monoclonal antibodies to mammalian neurofilaments
John N. Wood;Brian H. Anderton.
Bioscience Reports (1981)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
King's College London
University of Oxford
King's College London
King's College London
University College London
Mayo Clinic
King's College London
Queen Mary University of London
King's College London
University College London
Dartmouth College
Imperial College London
Australian National University
Yale University
Xi'an Jiaotong University
Technical University of Madrid
University of Clermont Auvergne
Chinese Academy of Sciences
University of Miami
Ames Research Center
University of Vienna
University of Melbourne
Kyoto University
University College London
University of Michigan–Ann Arbor
University of Basel